Dr. Graubert is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit Street
Boston, MA 02114
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 1993 - 1997
- Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 1991 - 1993
- Yale-New Haven Medical CenterResidency, Internal Medicine, 1988 - 1991
- Harvard Medical SchoolClass of 1988
Certifications & Licensure
- MA State Medical License 2013 - 2026
- MO State Medical License 1997 - 2014
- CT State Medical License 1990 - 1994
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Identification of Novel Genetic Factors That Contribute to Risk for Breast Cancer Start of enrollment: 2005 Mar 01
- Carfilzomib, Pegylated Liposomal Doxorubicin Hydrochloride, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma Start of enrollment: 2012 May 14
- Azacitidine in Patients Undergoing Matched Unrelated Stem Cell Transplantation Start of enrollment: 2013 Apr 15
- Join now to see all
Publications & Presentations
PubMed
- 99 citationsClonal architecture of secondary acute myeloid leukemia defined by single-cell sequencing.Andrew E. O. Hughes, Vincent Magrini, Ryan Demeter, Christopher A. Miller, Robert S. Fulton
Plos Genetics. 2014-07-10 - 134 citationsCellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potential.Terrence N. Wong, Christopher A. Miller, Matthew Rm Jotte, Nusayba Bagegni, Jack Baty
Nature Communications. 2018-01-31 - 459 citationsRecurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromesTimothy A. Graubert, Dong Shen, Li Ding, Theresa Okeyo-Owuor, Cara L Lunn
Nature Genetics. 2012-01-01
Press Mentions
- Dana-Farber Receives $5 Million Gift to Create the Edward P. Evans Center for MDSSeptember 16th, 2019
- $11.5 Million Supports Innovation in Leukemia ResearchNovember 6th, 2018
- Expert Point of View: Robert Hromas, MDJanuary 26th, 2016
- Join now to see all
Grant Support
- Genomics Of Treatment -Related Acute Myelogenous Leukemia: Susceptibility FactorsNational Cancer Institute2008–2012
- High Speed Cell Sorter CoreNational Cancer Institute2010–2011
- Whole Genome Sequencing Of Myelodysplastic SyndromesNational Heart, Lung, And Blood Institute2009–2010
- Genomics Of Myelodysplastic SyndromesNational Heart, Lung, And Blood Institute2005–2008
- Core--High Speed Cell Sorter FacilityNational Cancer Institute2004–2008
- Acquistion Of An Influx GMP Cell Sorter: Infectious DiseaseNational Center For Research Resources2005
- Acquistion Of An Influx GMP Cell Sorter: ImmunologyNational Center For Research Resources2005
- Acquistion Of An Influx GMP Cell Sorter: Adult Human Stem CellsNational Center For Research Resources2005
- Acquistion Of An Influx GMP Cell Sorter.National Center For Research Resources2005
- Genetic Targeting Of Hematopoietic Stem CellsNational Heart, Lung, And Blood Institute1998–2002
- Acquistion Of A Cytomation Moflo Cell SorterNational Center For Research Resources2001
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: